NR

Nanjaraju Raj Sukruthi

Active Director Designated Partner DIN 11525191
DIN 11525191 First appointment Feb 2026 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Nanjaraju Raj Sukruthi

Data last updated:

Nanjaraju Raj Sukruthi is a Designated Partner at Leogenix Pharmaceuticals Llp (since 2026). The company operates in Pharma.

DIN 11525191
Primary Designation Designated Partner
Industry Pharma
First Appointment 05 Feb 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner05 Feb 20262026Active

Board colleagues of Nanjaraju Raj Sukruthi

NameDINCompanyDesignation
Roopeshgowda11525190Leogenix Pharmaceuticals LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Leogenix Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Nanjaraju Raj Sukruthi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nanjaraju Raj Sukruthi

Nanjaraju Raj Sukruthi currently holds 1 directorship: Leogenix Pharmaceuticals Llp (Designated Partner, since 05 Feb 2026).

Nanjaraju Raj Sukruthi was first appointed on 05 Feb 2026 as Designated Partner at Leogenix Pharmaceuticals Llp.

The current boards of Nanjaraju Raj Sukruthi's companies include Roopeshgowda (Leogenix Pharmaceuticals Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available